|
End-of-day quote
Korea S.E.
28/09/2026
|
5-day change | 1st Jan Change | ||
| 1,856.00 KRW | +0.11% |
|
+0.05% | -62.88% |
| Market Cap | 28.2B 20.72M 18.22M 17.23M 15.63M 29.36M 1.99B 29.53M 206M 79.69M 1.02B 77.8M 76.11M 3.26B | P/E 2024 |
-2.12x | P/E 2025 | -9.5x |
|---|---|---|---|---|---|
| Enterprise Value | 11.01B 8.09M 7.11M 6.73M 6.1M 11.46M 776M 11.52M 80.54M 31.11M 396M 30.37M 29.71M 1.27B | EV / Sales 2024 |
4.85x | EV / Sales 2025 | 3.87x |
| Free-Float |
41.27% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.11% | ||
| 1 week | +0.05% | ||
| Current month | -0.22% | ||
| 1 month | -1.01% | ||
| 3 months | +9.69% | ||
| 6 months | -45.09% | ||
| Current year | -62.88% |
| 1 week | 1,852 |  | 2,005 |
| 1 month | 1,717 | | 2,005 |
| Current year | 1,430 | | 5,400 |
| 1 year | 1,430 | | 6,760 |
| 3 years | 1,430 | | 27,680 |
| 5 years | 1,430 | | 82,600 |
| 10 years | 1,430 | | 426,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jung-Chool Kim
CEO | Chief Executive Officer | 70 | 23/03/2022 |
Young-Suk Yeom
AUD | Comptroller/Controller/Auditor | 51 | - |
Jong-Su Kang
SAM | Sales & Marketing | 62 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Soon-Kyu Park
BRD | Director/Board Member | 59 | - |
Jung-Chool Kim
BRD | Director/Board Member | 70 | 23/03/2022 |
Jae-Seob Kim
BRD | Director/Board Member | 63 | 10/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.11% | +0.05% | -71.62% | -92.50% | 20.63M | |
| -1.23% | +0.30% | +61.55% | +118.51% | 1,056B | |
| -2.23% | -1.15% | +46.52% | +70.85% | 655B | |
| -1.59% | -0.81% | +17.88% | +76.49% | 471B | |
| -1.84% | -4.23% | +36.16% | +39.23% | 342B | |
| -0.58% | +3.47% | +21.66% | +28.37% | 277B | |
| -0.58% | -2.13% | +11.85% | +11.71% | 257B | |
| -0.57% | +1.61% | +52.15% | +55.10% | 226B | |
| -2.01% | -1.63% | +33.36% | +100.41% | 189B | |
| -0.27% | -2.96% | -28.55% | -61.00% | 170B | |
| Average | -1.08% | +1.04% | +18.09% | +34.72% | 364.29B | |
| Weighted average by Cap. | -1.32% | +1.04% | +38.04% | +69.43% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.4B 12.05M 10.6M 10.02M 9.09M 17.07M 1.16B 17.17M 120M 46.35M 590M 45.25M 44.27M 1.9B | 9.81B 7.21M 6.34M 5.99M 5.44M 10.21M 692M 10.27M 71.77M 27.72M 353M 27.06M 26.47M 1.13B |
| Net income | -28.09B -20.64M -18.16M -17.17M -15.57M -29.25M -1.98B -29.42M -206M -79.4M -1.01B -77.51M -75.83M -3.25B | -5.56B -4.09M -3.59M -3.4M -3.08M -5.79M -392M -5.82M -40.68M -15.71M -200M -15.34M -15.01M -643M |
| Net Debt | -25.07B -18.42M -16.2M -15.32M -13.9M -26.1M -1.77B -26.25M -183M -70.84M -902M -69.16M -67.66M -2.9B | -17.19B -12.63M -11.11M -10.51M -9.53M -17.9M -1.21B -18M -126M -48.59M -619M -47.43M -46.41M -1.99B |
Employees
11
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | ₩1,864.00 | +0.43% | 660 |
| 28/09/26 | ₩1,856.00 | +0.11% | 2,718 |
| 23/09/26 | ₩1,854.00 | -1.59% | 1,130 |
| 22/09/26 | ₩1,884.00 | +1.56% | 859 |
- Stock Market
- Stocks
- A109960 Stock
Select your edition
All financial news and data tailored to specific country editions
